FEXOFENADINE HYDROCHLORIDE

FEXOFENADINE HYDROCHLORIDE was reported 22271 times

FEXOFENADINE HYDROCHLORIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 VASCULAR ACCESS SITE COMPLICATION 14 0.0556
1 NEUROSIS 14 0.0310
2 PERSISTENT DEPRESSIVE DISORDER 12 0.0297
3 LABELLED DRUG-FOOD INTERACTION MEDICATION ERROR 13 0.0261
4 NASAL PRURITUS 25 0.0200
5 ECZEMA HERPETICUM 9 0.0194
6 PATIENT UNCOOPERATIVE 9 0.0190
7 INFUSION SITE DISCHARGE 32 0.0182
8 EXTRA DOSE ADMINISTERED 721 0.0178
9 CHRONIC SPONTANEOUS URTICARIA 20 0.0172
10 PRE-EXISTING CONDITION IMPROVED 102 0.0163
11 INFUSION SITE BRUISING 35 0.0162
12 CROUP INFECTIOUS 12 0.0152
13 SEASONAL ALLERGY 198 0.0140
14 WRONG DOSE 32 0.0132
15 INFUSION SITE PRURITUS 39 0.0123
16 INFUSION SITE IRRITATION 15 0.0117
17 MAST CELL ACTIVATION SYNDROME 16 0.0114
18 MULTIPLE ALLERGIES 87 0.0111
19 SLEEP-RELATED EATING DISORDER 10 0.0107
20 SKIN WEEPING 38 0.0106
21 CATAPLEXY 15 0.0106
22 ALLERGIC SINUSITIS 9 0.0105
23 SNEEZING 235 0.0105
24 INFUSION SITE MASS 11 0.0101
25 INFUSION SITE HAEMORRHAGE 33 0.0100
26 STEROID WITHDRAWAL SYNDROME 10 0.0098
27 OBSTRUCTIVE SLEEP APNOEA SYNDROME 14 0.0096
28 ALLERGIC REACTION TO EXCIPIENT 19 0.0095
29 EXPOSURE TO TOXIC AGENT 30 0.0094
30 NASAL SEPTUM DEVIATION 18 0.0092
31 PRODUCT ADMINISTRATION INTERRUPTED 72 0.0092
32 INFUSION SITE WARMTH 11 0.0090
33 POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME 12 0.0089
34 INFUSION SITE RASH 12 0.0087
35 ALLERGY TO ANIMAL 9 0.0084
36 INFUSION SITE PAIN 106 0.0082
37 POST-ACUTE COVID-19 SYNDROME 10 0.0081
38 NARCOLEPSY 15 0.0079
39 INFUSION SITE ERYTHEMA 67 0.0079
40 MICROCEPHALY 10 0.0078
41 INFUSION SITE SWELLING 46 0.0073
42 PRODUCT USE COMPLAINT 115 0.0073
43 PRODUCT PACKAGING DIFFICULT TO OPEN 19 0.0073
44 DEVICE INFUSION ISSUE 18 0.0073
45 QUADRIPARESIS 12 0.0072
46 THERAPEUTIC RESPONSE DECREASED 430 0.0071
47 UPPER-AIRWAY COUGH SYNDROME 57 0.0069
48 SNORING 26 0.0069
49 ABNORMAL SLEEP-RELATED EVENT 9 0.0068
50 CONVERSION DISORDER 13 0.0067
51 INTELLECTUAL DISABILITY 10 0.0066
52 AGORAPHOBIA 9 0.0066
53 DERMATITIS CONTACT 75 0.0066
54 RHINITIS ALLERGIC 29 0.0065
55 EYE ALLERGY 10 0.0065
56 MIDDLE EAR EFFUSION 14 0.0063
57 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 38 0.0062
58 NOROVIRUS INFECTION 9 0.0062
59 EXPIRED PRODUCT ADMINISTERED 205 0.0062
60 INFUSION SITE INDURATION 9 0.0061
61 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 102 0.0060
62 EYELID PAIN 12 0.0059
63 EAR CONGESTION 16 0.0059
64 SLEEP APNOEA SYNDROME 110 0.0058
65 ADRENAL DISORDER 11 0.0057
66 RHINORRHOEA 370 0.0057
67 DRUG EFFECT DELAYED 25 0.0055
68 PARANASAL SINUS HYPERSECRETION 21 0.0055
69 ESSENTIAL HYPERTENSION 10 0.0055
70 BODY TEMPERATURE ABNORMAL 10 0.0054
71 EOSINOPHILIC OESOPHAGITIS 15 0.0054
72 PRODUCT PACKAGE ASSOCIATED INJURY 12 0.0054
73 SENSITIVE SKIN 39 0.0053
74 INSURANCE ISSUE 80 0.0052
75 ORAL PRURITUS 12 0.0052
76 HANGOVER 18 0.0051
77 SINUS HEADACHE 30 0.0050
78 HEREDITARY ANGIOEDEMA 54 0.0050
79 REBOUND ATOPIC DERMATITIS 10 0.0050
80 NASAL DRYNESS 31 0.0049
81 EYE PRURITUS 166 0.0049
82 LACRIMATION INCREASED 147 0.0049
83 TEMPOROMANDIBULAR JOINT SYNDROME 13 0.0049
84 SINUS DISORDER 96 0.0048
85 SKIN FISSURES 94 0.0048
86 EAR DISORDER 22 0.0048
87 DERMATITIS ATOPIC 253 0.0048
88 AUTONOMIC NERVOUS SYSTEM IMBALANCE 14 0.0048
89 PARANASAL SINUS DISCOMFORT 18 0.0048
90 RESPIRATORY TRACT INFECTION VIRAL 11 0.0047
91 SOMNAMBULISM 31 0.0047
92 ENURESIS 19 0.0047
93 INFUSION SITE REACTION 14 0.0047
94 PRODUCT SIZE ISSUE 25 0.0046
95 THERAPEUTIC RESPONSE SHORTENED 152 0.0046
96 PSYCHOMOTOR SKILLS IMPAIRED 12 0.0046
97 NO ADVERSE EVENT 827 0.0046
98 FOOD ALLERGY 35 0.0045
99 HYPERTONIC BLADDER 13 0.0045
100 DRUG EFFECT LESS THAN EXPECTED 65 0.0044
101 BRAIN FOG 68 0.0043
102 LACTOSE INTOLERANCE 11 0.0043
103 DRUG TOLERANCE 21 0.0041
104 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 11 0.0041
105 COLONOSCOPY 9 0.0041
106 PERIORBITAL SWELLING 23 0.0041
107 GASTROENTERITIS VIRAL 73 0.0040
108 EUPHORIC MOOD 41 0.0040
109 EAR PRURITUS 14 0.0040
110 SINUSITIS 406 0.0040
111 PRODUCT TASTE ABNORMAL 53 0.0039
112 IMPAIRED QUALITY OF LIFE 56 0.0039
113 SKIN INFECTION 43 0.0038
114 NASAL CONGESTION 225 0.0038
115 PRODUCT PACKAGING ISSUE 36 0.0038
116 NASAL DISORDER 10 0.0038
117 DRUG EFFECT INCOMPLETE 136 0.0037
118 THERAPEUTIC PRODUCT EFFECT DELAYED 17 0.0037
119 SKIN DISCOMFORT 10 0.0037
120 WRONG PRODUCT ADMINISTERED 25 0.0037
121 DRY EYE 184 0.0037
122 BRONCHITIS CHRONIC 9 0.0037
123 PHARYNGEAL SWELLING 36 0.0037
124 ARTHROPOD BITE 27 0.0036
125 SKIN HAEMORRHAGE 54 0.0036
126 RHINALGIA 10 0.0036
127 CHOKING SENSATION 20 0.0036
128 DIZZINESS POSTURAL 35 0.0036
129 THERAPEUTIC PRODUCT EFFECT VARIABLE 14 0.0036
130 PRODUCT DISTRIBUTION ISSUE 33 0.0036
131 SINUS CONGESTION 48 0.0035
132 NASAL DISCOMFORT 28 0.0035
133 SCRATCH 37 0.0035
134 EAR INFECTION 92 0.0035
135 SKIN SWELLING 30 0.0035
136 ECZEMA 180 0.0034
137 VULVOVAGINAL PRURITUS 17 0.0034
138 DRY THROAT 34 0.0033
139 RESPIRATORY TRACT INFECTION 87 0.0033
140 PRODUCT COLOUR ISSUE 17 0.0033
141 VASCULAR DEVICE INFECTION 15 0.0033
142 ORAL FUNGAL INFECTION 9 0.0033
143 HEAD DISCOMFORT 58 0.0033
144 METASTASES TO SPINE 11 0.0033
145 FEELING DRUNK 24 0.0032
146 NEURODERMATITIS 12 0.0032
147 INITIAL INSOMNIA 33 0.0032
148 EYELIDS PRURITUS 10 0.0032
149 UPPER RESPIRATORY TRACT INFECTION 148 0.0032
150 FEELING JITTERY 61 0.0032
151 SWELLING OF EYELID 20 0.0032
152 DRUG ERUPTION 56 0.0032
153 SOMNOLENCE 635 0.0032
154 OROPHARYNGEAL DISCOMFORT 28 0.0031
155 SKIN WARM 18 0.0031
156 RESPIRATORY TRACT CONGESTION 49 0.0031
157 PEMPHIGOID 23 0.0030
158 THROAT IRRITATION 135 0.0030
159 POOR VENOUS ACCESS 31 0.0030
160 EYE DISCHARGE 31 0.0030
161 FUNGAL SKIN INFECTION 12 0.0030
162 SPINAL FUSION SURGERY 12 0.0030
163 SECRETION DISCHARGE 37 0.0030
164 CHRONIC SINUSITIS 11 0.0029
165 INTENTIONAL DOSE OMISSION 83 0.0029
166 AUTOIMMUNE THYROIDITIS 11 0.0029
167 DRUG INEFFECTIVE 3801 0.0029
168 PRODUCT FORMULATION ISSUE 19 0.0029
169 ACCIDENTAL OVERDOSE 105 0.0029
170 ASTHMA 323 0.0029
171 SKIN MASS 19 0.0028
172 NASAL POLYPS 14 0.0028
173 FOREIGN BODY SENSATION IN EYES 18 0.0028
174 GASTROINTESTINAL MOTILITY DISORDER 15 0.0028
175 ILLNESS 288 0.0028
176 EYE SWELLING 104 0.0028
177 BRUXISM 15 0.0028
178 HORDEOLUM 12 0.0028
179 ENTEROCOLITIS 16 0.0028
180 VITAMIN D DEFICIENCY 27 0.0028
181 CHAPPED LIPS 12 0.0028
182 TOOTH INJURY 12 0.0028
183 OCULAR DISCOMFORT 31 0.0028
184 OBSTRUCTION 11 0.0028
185 UNEVALUABLE EVENT 208 0.0027
186 SKIN PAPILLOMA 11 0.0027
187 BLEPHARITIS 11 0.0027
188 EAR DISCOMFORT 28 0.0027
189 ENDOMETRIOSIS 13 0.0027
190 HYPERKERATOSIS 15 0.0027
191 PELVIC FRACTURE 21 0.0027
192 TRIGGER FINGER 11 0.0027
193 THERAPEUTIC RESPONSE UNEXPECTED 120 0.0027
194 URINARY TRACT DISORDER 12 0.0027
195 PRODUCT PRESCRIBING ISSUE 58 0.0027
196 ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD 18 0.0026
197 BRONCHITIS 195 0.0026
198 PRODUCT DOSE OMISSION IN ERROR 74 0.0026
199 THYROID MASS 10 0.0026
200 MOUTH SWELLING 15 0.0026
201 SYNOVIAL CYST 12 0.0026
202 PRODUCT RESIDUE PRESENT 14 0.0026
203 NEPHROGENIC ANAEMIA 12 0.0026
204 ERYTHEMA OF EYELID 14 0.0026
205 INCORRECT DRUG ADMINISTRATION RATE 11 0.0026
206 SLEEP DISORDER 182 0.0026
207 HYPERSENSITIVITY 478 0.0026
208 SPINAL CORD COMPRESSION 10 0.0026
209 URTICARIA 429 0.0026
210 TENSION HEADACHE 11 0.0026
211 PRURITUS 971 0.0025
212 SKIN EXFOLIATION 213 0.0025
213 TRISMUS 13 0.0025
214 EYE PAIN 142 0.0025
215 EYE INFECTION 28 0.0025
216 VITAMIN B12 DEFICIENCY 10 0.0025
217 EAR PAIN 48 0.0025
218 IMMUNE-MEDIATED ENTEROCOLITIS 9 0.0024
219 AMYLASE INCREASED 9 0.0024
220 SPINAL OPERATION 30 0.0024
221 EXPOSURE VIA SKIN CONTACT 63 0.0024
222 NEURALGIA 59 0.0024
223 COMPRESSION FRACTURE 13 0.0024
224 SMALL FOR DATES BABY 12 0.0024
225 HYPERVENTILATION 14 0.0024
226 ABDOMINAL HERNIA 11 0.0024
227 CHOKING 47 0.0024
228 PNEUMONIA BACTERIAL 22 0.0024
229 THERMAL BURN 17 0.0024
230 WEIGHT FLUCTUATION 25 0.0024
231 ATTENTION DEFICIT HYPERACTIVITY DISORDER 10 0.0024
232 PRODUCTIVE COUGH 113 0.0024
233 PRODUCT LABEL ISSUE 16 0.0024
234 PLEURISY 14 0.0024
235 MIDDLE INSOMNIA 44 0.0024
236 SYMPTOM RECURRENCE 14 0.0023
237 STREPTOCOCCAL INFECTION 13 0.0023
238 LIGAMENT SPRAIN 23 0.0023
239 POOR QUALITY SLEEP 50 0.0023
240 COUGH 651 0.0023
241 VIRAL UPPER RESPIRATORY TRACT INFECTION 11 0.0023
242 LIP SWELLING 77 0.0023
243 RASH MACULAR 80 0.0023
244 CHOLANGITIS 14 0.0023
245 FACIAL PAIN 20 0.0022
246 RHINITIS 18 0.0022
247 DRY MOUTH 181 0.0022
248 FEELING ABNORMAL 529 0.0022
249 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 12 0.0022
250 COVID-19 386 0.0022
251 HEPATIC FUNCTION ABNORMAL 82 0.0022
252 HYSTERECTOMY 19 0.0022
253 HYPERURICAEMIA 9 0.0022
254 CHOLECYSTECTOMY 25 0.0022
255 GASTROOESOPHAGEAL REFLUX DISEASE 175 0.0022
256 SURGERY 127 0.0022
257 DYSLIPIDAEMIA 11 0.0022
258 LARGE INTESTINE POLYP 15 0.0022
259 INTERVERTEBRAL DISC DEGENERATION 20 0.0022
260 APHONIA 30 0.0021
261 INSOMNIA 571 0.0021
262 COELIAC DISEASE 21 0.0021
263 PULMONARY TOXICITY 15 0.0021
264 SKIN ABRASION 10 0.0021
265 FOOT FRACTURE 40 0.0021
266 VITAMIN D DECREASED 18 0.0021
267 MIGRAINE 201 0.0021
268 DRY SKIN 281 0.0021
269 INFUSION SITE EXTRAVASATION 13 0.0021
270 OROPHARYNGEAL PAIN 193 0.0021
271 CARPAL TUNNEL SYNDROME 29 0.0021
272 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 373 0.0021
273 RESPIRATORY SYNCYTIAL VIRUS INFECTION 18 0.0021
274 BLEPHAROSPASM 13 0.0021
275 FOOD POISONING 11 0.0021
276 ONYCHOMYCOSIS 9 0.0020
277 BASAL CELL CARCINOMA 32 0.0020
278 VIRAL INFECTION 68 0.0020
279 GINGIVITIS 11 0.0020
280 ERYTHEMA MULTIFORME 19 0.0020
281 PHARYNGITIS STREPTOCOCCAL 22 0.0020
282 COVID-19 PNEUMONIA 24 0.0020
283 HIP SURGERY 11 0.0020
284 CATHETERISATION CARDIAC 9 0.0020
285 BACK DISORDER 33 0.0020
286 ASTHENOPIA 11 0.0020
287 IRON DEFICIENCY 9 0.0020
288 ORAL HERPES 39 0.0020
289 TOOTH FRACTURE 22 0.0020
290 SQUAMOUS CELL CARCINOMA OF SKIN 12 0.0020
291 PRODUCT PHYSICAL ISSUE 40 0.0020
292 PSEUDOMONAS INFECTION 17 0.0020
293 OCULAR HYPERAEMIA 94 0.0020
294 FUNGAL INFECTION 66 0.0020
295 CYSTITIS 63 0.0020
296 ADRENAL INSUFFICIENCY 24 0.0020
297 MUSCULOSKELETAL DISCOMFORT 34 0.0020
298 IMMUNE SYSTEM DISORDER 26 0.0020
299 TOOTH INFECTION 26 0.0020
300 RETCHING 42 0.0020
301 EPISTAXIS 147 0.0020
302 NIGHTMARE 68 0.0020
303 MUSCLE STRAIN 17 0.0020
304 THIRST 35 0.0020
305 IRRITABLE BOWEL SYNDROME 42 0.0020
306 DYSPNOEA EXERTIONAL 73 0.0019
307 SPINAL OSTEOARTHRITIS 17 0.0019
308 FEELING OF DESPAIR 9 0.0019
309 HYPERLIPIDAEMIA 23 0.0019
310 EOSINOPHIL COUNT INCREASED 16 0.0019
311 VERTIGO 117 0.0019
312 FURUNCLE 15 0.0019
313 ANAPHYLACTIC REACTION 104 0.0019
314 RESTLESS LEGS SYNDROME 34 0.0019
315 PHOTOPHOBIA 35 0.0019
316 INTERSTITIAL LUNG DISEASE 90 0.0019
317 NASOPHARYNGITIS 342 0.0019
318 WHEEZING 110 0.0019
319 FIBROMYALGIA 45 0.0018
320 MACULAR DEGENERATION 22 0.0018
321 SKIN LACERATION 20 0.0018
322 PRODUCT ADMINISTRATION ERROR 37 0.0018
323 PRODUCT DOSE OMISSION ISSUE 537 0.0018
324 DISCOMFORT 111 0.0018
325 FOOT OPERATION 9 0.0018
326 INJECTION SITE VESICLES 11 0.0018
327 PRODUCT USE IN UNAPPROVED INDICATION 450 0.0018
328 NOCTURIA 22 0.0018
329 CONCUSSION 14 0.0018
330 DERMATITIS ACNEIFORM 11 0.0018
331 PARAESTHESIA ORAL 26 0.0018
332 INFLUENZA 201 0.0018
333 APNOEA 14 0.0018
334 WRONG DRUG ADMINISTERED 16 0.0018
335 FAECES SOFT 13 0.0018
336 TASTE DISORDER 36 0.0018
337 BLOOD IRON DECREASED 21 0.0018
338 TOOTH ABSCESS 18 0.0018
339 PNEUMOTHORAX 28 0.0018
340 PRODUCT PRESCRIBING ERROR 42 0.0018
341 RENAL CYST 14 0.0018
342 PRODUCT USE ISSUE 330 0.0018
343 EYE IRRITATION 101 0.0018
344 AUTOIMMUNE DISORDER 17 0.0017
345 DYSPHONIA 102 0.0017
346 INTERVERTEBRAL DISC PROTRUSION 38 0.0017
347 ABDOMINAL DISCOMFORT 291 0.0017
348 SCHIZOPHRENIA 21 0.0017
349 PAROSMIA 13 0.0017
350 POST PROCEDURAL INFECTION 14 0.0017
351 FEELING OF BODY TEMPERATURE CHANGE 10 0.0017
352 EYE DISORDER 56 0.0017
353 CARDIAC FLUTTER 11 0.0017
354 BOWEL MOVEMENT IRREGULARITY 13 0.0017
355 CONDITION AGGRAVATED 515 0.0017
356 LIMB INJURY 46 0.0017
357 ANKLE FRACTURE 26 0.0017
358 HEART RATE INCREASED 166 0.0017
359 CONJUNCTIVITIS 31 0.0017
360 DERMATITIS 35 0.0017
361 DERMATITIS ALLERGIC 21 0.0017
362 WRIST FRACTURE 20 0.0017
363 TOOTH DISORDER 37 0.0017
364 PANIC REACTION 12 0.0017
365 ALTERED STATE OF CONSCIOUSNESS 36 0.0017
366 RASH 724 0.0017
367 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 335 0.0017
368 CARDIAC FAILURE ACUTE 11 0.0016
369 INJECTION SITE IRRITATION 21 0.0016
370 INTENTIONAL UNDERDOSE 12 0.0016
371 RASH PRURITIC 89 0.0016
372 KIDNEY INFECTION 32 0.0016
373 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 116 0.0016
374 INJECTION SITE RASH 50 0.0016
375 ATRIAL FLUTTER 13 0.0016
376 THROAT TIGHTNESS 44 0.0016
377 CYSTIC FIBROSIS 9 0.0016
378 BLOOD PRESSURE DECREASED 108 0.0016
379 NERVE COMPRESSION 15 0.0016
380 HYPOPHOSPHATAEMIA 12 0.0016
381 CONCOMITANT DISEASE AGGRAVATED 10 0.0016
382 PIGMENTATION DISORDER 10 0.0016
383 SCOLIOSIS 10 0.0016
384 LYMPHADENOPATHY 57 0.0016
385 GLAUCOMA 31 0.0016
386 HEADACHE 1006 0.0016
387 PERIPHERAL COLDNESS 22 0.0016
388 OXYGEN SATURATION DECREASED 90 0.0016
389 SALIVARY HYPERSECRETION 16 0.0016
390 RESPIRATION ABNORMAL 11 0.0016
391 BLOOD PRESSURE INCREASED 244 0.0016
392 TENDON PAIN 12 0.0016
393 INTENTIONAL PRODUCT MISUSE 138 0.0016
394 INTENTIONAL PRODUCT USE ISSUE 138 0.0016
395 SPINAL COMPRESSION FRACTURE 13 0.0016
396 SLUGGISHNESS 16 0.0016
397 PALPITATIONS 183 0.0016
398 GASTROINTESTINAL INFECTION 14 0.0016
399 PNEUMONIA ASPIRATION 39 0.0016
400 POLLAKIURIA 65 0.0016
401 FLUID RETENTION 79 0.0016
402 PRESCRIBED OVERDOSE 30 0.0015
403 HERPES ZOSTER 89 0.0015
404 NEUTROPHIL COUNT DECREASED 63 0.0015
405 DIPLOPIA 40 0.0015
406 ANGIOEDEMA 68 0.0015
407 SWELLING FACE 100 0.0015
408 ELECTROCARDIOGRAM ABNORMAL 12 0.0015
409 PRODUCT ODOUR ABNORMAL 16 0.0015
410 INCORRECT PRODUCT ADMINISTRATION DURATION 33 0.0015
411 GLUCOSE TOLERANCE IMPAIRED 9 0.0015
412 INCREASED TENDENCY TO BRUISE 14 0.0015
413 ORAL CANDIDIASIS 20 0.0015
414 CATARACT OPERATION 9 0.0015
415 APPETITE DISORDER 10 0.0015
416 BLOOD MAGNESIUM DECREASED 13 0.0015
417 RASH ERYTHEMATOUS 72 0.0015
418 SKIN DISORDER 50 0.0015
419 POST-TRAUMATIC STRESS DISORDER 10 0.0015
420 INJECTION SITE SWELLING 114 0.0015
421 CEREBRAL DISORDER 11 0.0015
422 MYASTHENIA GRAVIS 12 0.0015
423 DIZZINESS 741 0.0015
424 FRUSTRATION TOLERANCE DECREASED 12 0.0015
425 DECREASED ACTIVITY 16 0.0015
426 CANDIDA INFECTION 25 0.0015
427 ROTATOR CUFF SYNDROME 19 0.0015
428 SPUTUM DISCOLOURED 14 0.0015
429 NERVOUSNESS 77 0.0015
430 LYMPHOCYTE COUNT DECREASED 26 0.0015
431 PULMONARY THROMBOSIS 16 0.0015
432 INJECTION SITE URTICARIA 36 0.0015
433 HYPERSOMNIA 42 0.0015
434 NEPHROLITHIASIS 67 0.0015
435 URINARY TRACT INFECTION 249 0.0015
436 STAPHYLOCOCCAL INFECTION 48 0.0015
437 PANIC ATTACK 53 0.0015
438 PHARYNGITIS 18 0.0014
439 INJECTION SITE PRURITUS 96 0.0014
440 NIGHT SWEATS 46 0.0014
441 ERYTHEMA 293 0.0014
442 KNEE OPERATION 14 0.0014
443 CHEST DISCOMFORT 145 0.0014
444 DYSURIA 52 0.0014
445 PAIN OF SKIN 38 0.0014
446 DIVERTICULITIS 39 0.0014
447 GASTROINTESTINAL INFLAMMATION 11 0.0014
448 NECK PAIN 78 0.0014
449 DYSPHAGIA 132 0.0014
450 PERIPHERAL SWELLING 214 0.0014
451 ANXIETY 395 0.0014
452 PSYCHOMOTOR HYPERACTIVITY 23 0.0014
453 PYELONEPHRITIS 12 0.0014
454 ORAL PAIN 31 0.0014
455 TOOTHACHE 25 0.0014
456 BACK INJURY 15 0.0014
457 BRADYPHRENIA 9 0.0014
458 HYPOKINESIA 20 0.0014
459 PAIN IN JAW 39 0.0014
460 SENSORY DISTURBANCE 22 0.0014
461 HYPOGAMMAGLOBULINAEMIA 9 0.0014
462 VISION BLURRED 188 0.0014
463 MAJOR DEPRESSION 10 0.0014
464 BLOOD CALCIUM INCREASED 12 0.0014
465 HUNGER 19 0.0014
466 THERAPEUTIC PRODUCT EFFECT DECREASED 61 0.0014
467 MUSCULOSKELETAL CHEST PAIN 21 0.0014
468 DENTAL CARIES 15 0.0014
469 CEREBRAL INFARCTION 33 0.0013
470 MUSCLE TWITCHING 31 0.0013
471 CHOLECYSTITIS 16 0.0013
472 MYOSITIS 12 0.0013
473 ANAL INCONTINENCE 12 0.0013
474 CONSTIPATION 290 0.0013
475 CHROMATURIA 30 0.0013
476 DEPRESSED MOOD 70 0.0013
477 ARTHRITIS 104 0.0013
478 ORTHOSTATIC HYPOTENSION 23 0.0013
479 HOSPICE CARE 13 0.0013
480 HOT FLUSH 99 0.0013
481 BLADDER DISORDER 13 0.0013
482 SENSATION OF FOREIGN BODY 11 0.0013
483 LYMPHOEDEMA 9 0.0013
484 MUSCLE TIGHTNESS 21 0.0013
485 HEAD INJURY 41 0.0013
486 HYPOALBUMINAEMIA 10 0.0013
487 HYPOTHYROIDISM 41 0.0013
488 HEART RATE IRREGULAR 29 0.0013
489 FATIGUE 999 0.0013
490 NEUROPATHY PERIPHERAL 122 0.0013
491 KNEE ARTHROPLASTY 27 0.0013
492 SWOLLEN TONGUE 40 0.0013
493 BACK PAIN 296 0.0013
494 PNEUMONIA 412 0.0013
495 STOMATITIS 77 0.0013
496 CONTUSION 122 0.0013
497 LOSS OF CONSCIOUSNESS 162 0.0013
498 BLOOD POTASSIUM DECREASED 38 0.0013
499 FOOT DEFORMITY 14 0.0013
500 FEAR OF INJECTION 9 0.0013
501 BRONCHOSPASM 18 0.0013
502 HYPOAESTHESIA ORAL 19 0.0013
503 LIMB DISCOMFORT 39 0.0013
504 ABDOMINAL PAIN UPPER 258 0.0013
505 DYSPNOEA 708 0.0012
506 CELLULITIS 63 0.0012
507 SWELLING 117 0.0012
508 POST PROCEDURAL COMPLICATION 24 0.0012
509 ANOSMIA 18 0.0012
510 HYPERCHOLESTEROLAEMIA 12 0.0012
511 AGEUSIA 31 0.0012
512 SENSORY LOSS 10 0.0012
513 ANGER 42 0.0012
514 DIARRHOEA 801 0.0012
515 FULL BLOOD COUNT DECREASED 25 0.0012
516 INFUSION RELATED REACTION 82 0.0012
517 MITRAL VALVE INCOMPETENCE 14 0.0012
518 IMPAIRED DRIVING ABILITY 14 0.0012
519 ABNORMAL DREAMS 34 0.0012
520 DYSPEPSIA 121 0.0012
521 JOINT DISLOCATION 13 0.0012
522 INJECTION SITE BRUISING 98 0.0012
523 INFECTION 177 0.0012
524 TINNITUS 56 0.0012
525 HYPERHIDROSIS 157 0.0012
526 ESCHERICHIA INFECTION 10 0.0012
527 INJECTION SITE WARMTH 25 0.0012
528 GENERALISED OEDEMA 15 0.0012
529 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 58 0.0012
530 BLOOD PRESSURE ABNORMAL 24 0.0012
531 TOOTH EXTRACTION 15 0.0012
532 INCREASED APPETITE 23 0.0012
533 RESTLESSNESS 44 0.0012
534 EYE HAEMORRHAGE 16 0.0012
535 DECREASED APPETITE 278 0.0012
536 SEXUAL DYSFUNCTION 14 0.0012
537 CATARACT 71 0.0012
538 BALANCE DISORDER 103 0.0012
539 MYALGIA 202 0.0012
540 MUSCLE SPASMS 218 0.0012
541 DEPRESSION 270 0.0012
542 AORTIC ANEURYSM 9 0.0012
543 FLATULENCE 67 0.0012
544 OEDEMA 64 0.0012
545 ABDOMINAL DISTENSION 123 0.0012
546 GALLBLADDER DISORDER 21 0.0012
547 MALAISE 515 0.0012
548 DEVICE RELATED INFECTION 18 0.0012
549 LETHARGY 67 0.0012
550 INFLAMMATION 60 0.0012
551 TENDONITIS 18 0.0012
552 SPINAL DISORDER 11 0.0012
553 HIATUS HERNIA 15 0.0012
554 HYPERTENSION 245 0.0012
555 ORAL DISCOMFORT 16 0.0012
556 LIVER DISORDER 51 0.0011
557 GASTROINTESTINAL DISORDER 103 0.0011
558 GENERALISED TONIC-CLONIC SEIZURE 19 0.0011
559 ROAD TRAFFIC ACCIDENT 48 0.0011
560 HAEMOPTYSIS 32 0.0011
561 SEDATION 30 0.0011
562 AFFECTIVE DISORDER 9 0.0011
563 FEELING HOT 70 0.0011
564 PULMONARY MASS 17 0.0011
565 INJECTION SITE DISCOMFORT 12 0.0011
566 SCAB 13 0.0011
567 GROIN PAIN 10 0.0011
568 HERNIA 22 0.0011
569 TREMOR 188 0.0011
570 WEIGHT DECREASED 316 0.0011
571 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 10 0.0011
572 GINGIVAL PAIN 9 0.0011
573 WEIGHT INCREASED 253 0.0011
574 SCIATICA 18 0.0011
575 OSTEOPENIA 17 0.0011
576 HEPATOMEGALY 11 0.0011
577 RED BLOOD CELL COUNT DECREASED 32 0.0011
578 QUALITY OF LIFE DECREASED 15 0.0011
579 BODY TEMPERATURE DECREASED 11 0.0011
580 NAUSEA 884 0.0011
581 LOCALISED INFECTION 27 0.0011
582 DISABILITY 22 0.0011
583 INJECTION SITE PAIN 341 0.0011
584 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 61 0.0011
585 ABNORMAL BEHAVIOUR 44 0.0011
586 PHARYNGEAL OEDEMA 17 0.0011
587 COMPLICATION ASSOCIATED WITH DEVICE 16 0.0011
588 LIP DRY 10 0.0011
589 OVARIAN CYST 11 0.0011
590 BACTERAEMIA 13 0.0011
591 ATAXIA 13 0.0011
592 TOXIC SKIN ERUPTION 11 0.0011
593 GASTROINTESTINAL PAIN 12 0.0011
594 PHOTOSENSITIVITY REACTION 18 0.0011
595 SKIN DISCOLOURATION 50 0.0011
596 ACCIDENTAL EXPOSURE TO PRODUCT 112 0.0011
597 METASTASES TO CENTRAL NERVOUS SYSTEM 14 0.0011
598 MEMORY IMPAIRMENT 149 0.0011
599 SKIN ULCER 28 0.0011
600 DEHYDRATION 144 0.0011
601 NERVE INJURY 12 0.0011
602 FALL 356 0.0011
603 REBOUND EFFECT 12 0.0011
604 WHITE BLOOD CELL COUNT DECREASED 115 0.0011
605 HAEMATOCRIT DECREASED 21 0.0011
606 DYSMENORRHOEA 14 0.0011
607 ADVERSE REACTION 14 0.0011
608 TENDERNESS 11 0.0011
609 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 55 0.0011
610 TENDON RUPTURE 13 0.0011
611 PRESCRIBED UNDERDOSE 21 0.0011
612 SCAR 18 0.0011
613 HALLUCINATION 79 0.0010
614 EYE INFLAMMATION 10 0.0010
615 SKIN IRRITATION 48 0.0010
616 CYST 13 0.0010
617 ARTHRALGIA 435 0.0010
618 OSTEOPOROSIS 43 0.0010
619 RESPIRATORY DISORDER 31 0.0010
620 METASTASES TO BONE 17 0.0010
621 PULMONARY ARTERIAL HYPERTENSION 15 0.0010
622 IRRITABILITY 62 0.0010
623 NEEDLE ISSUE 30 0.0010
624 JOINT INJURY 22 0.0010
625 BLOOD CHOLESTEROL INCREASED 48 0.0010
626 BODY HEIGHT DECREASED 11 0.0010
627 IMPAIRED GASTRIC EMPTYING 14 0.0010
628 ATRIAL FIBRILLATION 100 0.0010
629 DYSGEUSIA 76 0.0010
630 HEPATIC STEATOSIS 19 0.0010
631 DRUG-INDUCED LIVER INJURY 32 0.0010
632 URINARY RETENTION 34 0.0010
633 VITREOUS FLOATERS 10 0.0010
634 FAECES DISCOLOURED 22 0.0010
635 OSTEOARTHRITIS 43 0.0010
636 FLUSHING 103 0.0010
637 SEIZURE 117 0.0010
638 DISORIENTATION 40 0.0010
639 RENAL DISORDER 47 0.0010
640 PULMONARY HYPERTENSION 21 0.0010
641 BLOOD SODIUM DECREASED 19 0.0010
642 CLOSTRIDIUM DIFFICILE INFECTION 22 0.0010
643 ULCER 16 0.0010
644 HYPOMAGNESAEMIA 14 0.0010
645 WOUND INFECTION 11 0.0010
646 RASH GENERALISED 26 0.0010
647 PLATELET COUNT DECREASED 107 0.0010
648 HYPOCALCAEMIA 19 0.0010
649 GOUT 18 0.0010
650 FEMUR FRACTURE 31 0.0010
651 INJECTION SITE ERYTHEMA 124 0.0010
652 CHEST PAIN 185 0.0010
653 PYREXIA 344 0.0010
654 THERAPY INTERRUPTED 71 0.0010
655 PARAESTHESIA 156 0.0010
656 EMPHYSEMA 10 0.0010
657 LOWER LIMB FRACTURE 19 0.0010
658 HYPOAESTHESIA 148 0.0010
659 INJECTION SITE REACTION 68 0.0010
660 ASCITES 29 0.0010
661 SARS-COV-2 TEST POSITIVE 13 0.0010
662 DISTURBANCE IN ATTENTION 53 0.0010
663 CHILLS 115 0.0010
664 PAIN 601 0.0010
665 VOMITING 459 0.0010
666 SKIN CANCER 21 0.0010
667 IRON DEFICIENCY ANAEMIA 9 0.0010
668 HYPOKALAEMIA 45 0.0010
669 LYMPHOMA 15 0.0010
670 BACTERIAL INFECTION 18 0.0010
671 VENTRICULAR EXTRASYSTOLES 10 0.0010
672 INJECTION SITE DISCOLOURATION 12 0.0010
673 FLANK PAIN 9 0.0010
674 THERAPY NON-RESPONDER 43 0.0010
675 FOLLICULITIS 10 0.0010
676 SKIN BURNING SENSATION 68 0.0009
677 MENTAL IMPAIRMENT 23 0.0009
678 FACE OEDEMA 16 0.0009
679 CYTOKINE RELEASE SYNDROME 19 0.0009
680 ELECTROLYTE IMBALANCE 11 0.0009
681 BLOOD LACTATE DEHYDROGENASE INCREASED 15 0.0009
682 EYELID OEDEMA 11 0.0009
683 PRESYNCOPE 23 0.0009
684 MOOD SWINGS 30 0.0009
685 LUNG DISORDER 46 0.0009
686 HYPOXIA 33 0.0009
687 SPEECH DISORDER 49 0.0009
688 PAIN IN EXTREMITY 275 0.0009
689 ERUCTATION 18 0.0009
690 MASS 13 0.0009
691 SUICIDAL IDEATION 85 0.0009
692 PRODUCT PREPARATION ERROR 19 0.0009
693 CONTRAINDICATED PRODUCT ADMINISTERED 28 0.0009
694 HEPATIC ENZYME INCREASED 63 0.0009
695 HAEMORRHOIDS 18 0.0009
696 BLOOD GLUCOSE ABNORMAL 17 0.0009
697 HIP ARTHROPLASTY 14 0.0009
698 BURNING SENSATION 64 0.0009
699 GASTRITIS 24 0.0009
700 INABILITY TO AFFORD MEDICATION 9 0.0009
701 HEPATIC CIRRHOSIS 17 0.0009
702 DYSARTHRIA 34 0.0009
703 INFLUENZA LIKE ILLNESS 74 0.0009
704 BLOOD URINE PRESENT 17 0.0009
705 PROTEINURIA 17 0.0009
706 INTESTINAL PERFORATION 10 0.0009
707 GASTROENTERITIS 13 0.0009
708 DRUG INTOLERANCE 86 0.0009
709 ELECTROCARDIOGRAM QT PROLONGED 32 0.0009
710 SYNCOPE 89 0.0009
711 BLOOD CALCIUM DECREASED 10 0.0009
712 LIVER FUNCTION TEST INCREASED 19 0.0009
713 OSTEOMYELITIS 16 0.0009
714 WITHDRAWAL SYNDROME 37 0.0009
715 MUSCULAR WEAKNESS 100 0.0009
716 MUSCULOSKELETAL STIFFNESS 77 0.0009
717 PRURITUS GENERALISED 19 0.0009
718 OEDEMA PERIPHERAL 107 0.0009
719 ABSCESS 14 0.0009
720 BLOOD PRESSURE FLUCTUATION 21 0.0009
721 BLISTER 49 0.0009
722 COLON CANCER 13 0.0009
723 BLOOD PRESSURE SYSTOLIC INCREASED 17 0.0009
724 AGITATION 64 0.0009
725 ASPARTATE AMINOTRANSFERASE INCREASED 46 0.0009
726 METASTASES TO LUNG 10 0.0009
727 INJECTION SITE MASS 32 0.0009
728 VISUAL IMPAIRMENT 107 0.0009
729 BLOOD POTASSIUM INCREASED 14 0.0009
730 FEELING COLD 24 0.0009
731 MYDRIASIS 11 0.0009
732 STEVENS-JOHNSON SYNDROME 19 0.0009
733 DEVICE OCCLUSION 12 0.0009
734 DISSEMINATED INTRAVASCULAR COAGULATION 12 0.0009
735 FULL BLOOD COUNT ABNORMAL 9 0.0009
736 CLOSTRIDIUM DIFFICILE COLITIS 9 0.0008
737 SPINAL FRACTURE 17 0.0008
738 LABORATORY TEST ABNORMAL 25 0.0008
739 RENAL IMPAIRMENT 71 0.0008
740 PNEUMONITIS 23 0.0008
741 FEBRILE NEUTROPENIA 56 0.0008
742 DEAFNESS 22 0.0008
743 PSORIATIC ARTHROPATHY 34 0.0008
744 LOWER RESPIRATORY TRACT INFECTION 38 0.0008
745 PRODUCT AVAILABILITY ISSUE 19 0.0008
746 BLOOD CREATINE PHOSPHOKINASE INCREASED 24 0.0008
747 THERAPY PARTIAL RESPONDER 13 0.0008
748 TACHYCARDIA 74 0.0008
749 BURSITIS 10 0.0008
750 OESOPHAGITIS 9 0.0008
751 CIRCULATORY COLLAPSE 14 0.0008
752 ANAPHYLACTIC SHOCK 21 0.0008
753 COGNITIVE DISORDER 38 0.0008
754 HYPOACUSIS 35 0.0008
755 URINARY INCONTINENCE 24 0.0008
756 ARTHROPATHY 45 0.0008
757 ASTHENIA 304 0.0008
758 MOUTH ULCERATION 17 0.0008
759 MOOD ALTERED 22 0.0008
760 GLOSSODYNIA 18 0.0008
761 UPPER LIMB FRACTURE 16 0.0008
762 BONE PAIN 47 0.0008
763 CENTRAL NERVOUS SYSTEM LESION 11 0.0008
764 TUBULOINTERSTITIAL NEPHRITIS 15 0.0008
765 ALANINE AMINOTRANSFERASE INCREASED 49 0.0008
766 HEART RATE DECREASED 28 0.0008
767 HYPERGLYCAEMIA 29 0.0008
768 THROMBOSIS 64 0.0008
769 PROCEDURAL PAIN 22 0.0008
770 ACNE 60 0.0008
771 FEEDING DISORDER 16 0.0008
772 INTERNAL HAEMORRHAGE 9 0.0008
773 BODY TEMPERATURE INCREASED 16 0.0008
774 BLOOD TEST ABNORMAL 11 0.0008
775 INTRAOCULAR PRESSURE INCREASED 10 0.0008
776 SEPTIC SHOCK 34 0.0008
777 DRUG PRESCRIBING ERROR 15 0.0008
778 RIB FRACTURE 16 0.0008
779 DISEASE RECURRENCE 37 0.0008
780 PLEURAL EFFUSION 47 0.0008
781 INJECTION SITE INDURATION 10 0.0008
782 INCORRECT DOSE ADMINISTERED 176 0.0008
783 TRANSIENT ISCHAEMIC ATTACK 26 0.0008
784 C-REACTIVE PROTEIN INCREASED 28 0.0008
785 SKIN LESION 21 0.0008
786 CHOLELITHIASIS 25 0.0008
787 ARRHYTHMIA 36 0.0008
788 HAEMATURIA 26 0.0008
789 MEDICATION ERROR 42 0.0008
790 ACCIDENT 9 0.0008
791 DEVICE USE ISSUE 13 0.0007
792 INTESTINAL OBSTRUCTION 28 0.0007
793 EOSINOPHILIA 13 0.0007
794 METASTASES TO LIVER 13 0.0007
795 IMMUNODEFICIENCY 11 0.0007
796 COLD SWEAT 13 0.0007
797 BLOOD TRIGLYCERIDES INCREASED 13 0.0007
798 PERICARDIAL EFFUSION 17 0.0007
799 ALOPECIA 144 0.0007
800 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 17 0.0007
801 ACUTE RESPIRATORY FAILURE 14 0.0007
802 ILL-DEFINED DISORDER 44 0.0007
803 DEEP VEIN THROMBOSIS 47 0.0007
804 DEVICE FAILURE 11 0.0007
805 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 21 0.0007
806 MOVEMENT DISORDER 23 0.0007
807 THYROID DISORDER 11 0.0007
808 JOINT SWELLING 86 0.0007
809 GAIT DISTURBANCE 136 0.0007
810 DELUSION 11 0.0007
811 HYPOPHAGIA 18 0.0007
812 PARALYSIS 10 0.0007
813 THINKING ABNORMAL 13 0.0007
814 CARDIAC FAILURE 56 0.0007
815 CHRONIC KIDNEY DISEASE 53 0.0007
816 HOSPITALISATION 107 0.0007
817 DRUG INTERACTION 110 0.0007
818 PULMONARY OEDEMA 31 0.0007
819 ABDOMINAL PAIN 161 0.0007
820 PLASMA CELL MYELOMA 27 0.0007
821 ADVERSE DRUG REACTION 62 0.0007
822 PRODUCT DISPENSING ERROR 15 0.0007
823 HYPOTENSION 138 0.0007
824 CRYING 25 0.0007
825 FRACTURE 13 0.0007
826 JOINT STIFFNESS 18 0.0007
827 BEDRIDDEN 9 0.0007
828 DIABETES MELLITUS 52 0.0007
829 PULMONARY FIBROSIS 13 0.0007
830 GAMMA-GLUTAMYLTRANSFERASE INCREASED 15 0.0007
831 TREATMENT NONCOMPLIANCE 37 0.0007
832 SYSTEMIC LUPUS ERYTHEMATOSUS 24 0.0007
833 RASH MACULO-PAPULAR 15 0.0007
834 HAIR TEXTURE ABNORMAL 9 0.0007
835 HAEMATOCHEZIA 37 0.0007
836 ANAEMIA 127 0.0007
837 ERECTILE DYSFUNCTION 17 0.0007
838 BRADYCARDIA 35 0.0007
839 GAIT INABILITY 22 0.0007
840 UNDERDOSE 48 0.0007
841 EATING DISORDER 14 0.0007
842 WHITE BLOOD CELL COUNT INCREASED 25 0.0007
843 DYSSTASIA 19 0.0007
844 CONFUSIONAL STATE 105 0.0006
845 PRODUCT DOSE OMISSION 42 0.0006
846 THERAPY CESSATION 33 0.0006
847 PARANOIA 11 0.0006
848 MALIGNANT NEOPLASM PROGRESSION 65 0.0006
849 OFF LABEL USE 554 0.0006
850 DRUG EFFECT DECREASED 34 0.0006
851 AMNESIA 41 0.0006
852 MUSCULOSKELETAL PAIN 33 0.0006
853 FREQUENT BOWEL MOVEMENTS 17 0.0006
854 OBESITY 10 0.0006
855 SEPSIS 70 0.0006
856 INJURY 44 0.0006
857 RASH PAPULAR 14 0.0006
858 CARDIAC FAILURE CONGESTIVE 50 0.0006
859 HIP FRACTURE 20 0.0006
860 EPILEPSY 19 0.0006
861 DYSKINESIA 25 0.0006
862 BLOOD CREATININE INCREASED 40 0.0006
863 OVERDOSE 132 0.0006
864 EXPOSURE DURING PREGNANCY 38 0.0006
865 PULMONARY EMBOLISM 58 0.0006
866 CARDIOMYOPATHY 9 0.0006
867 WOUND 17 0.0006
868 HYPONATRAEMIA 34 0.0006
869 CYTOMEGALOVIRUS INFECTION 10 0.0006
870 COAGULOPATHY 10 0.0006
871 BLOOD UREA INCREASED 10 0.0006
872 ABDOMINAL PAIN LOWER 15 0.0006
873 BLOOD BILIRUBIN INCREASED 16 0.0006
874 BLINDNESS 24 0.0006
875 DRUG ADMINISTRATION ERROR 18 0.0006
876 LIVER FUNCTION TEST ABNORMAL 17 0.0006
877 BLOOD GLUCOSE DECREASED 28 0.0006
878 GASTRIC DISORDER 20 0.0006
879 DEPRESSED LEVEL OF CONSCIOUSNESS 23 0.0006
880 MENTAL DISORDER 25 0.0006
881 PRODUCT QUALITY ISSUE 78 0.0006
882 HALLUCINATION, VISUAL 12 0.0006
883 RHEUMATOID ARTHRITIS 64 0.0006
884 CARDIAC DISORDER 52 0.0006
885 ACUTE KIDNEY INJURY 85 0.0006
886 COLITIS 21 0.0006
887 END STAGE RENAL DISEASE 10 0.0005
888 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 14 0.0005
889 AGRANULOCYTOSIS 10 0.0005
890 DEMENTIA 15 0.0005
891 ANHEDONIA 14 0.0005
892 PERITONITIS 11 0.0005
893 HEPATIC FAILURE 16 0.0005
894 CORONARY ARTERY DISEASE 16 0.0005
895 RHABDOMYOLYSIS 22 0.0005
896 GASTRIC ULCER 10 0.0005
897 PRODUCT STORAGE ERROR 46 0.0005
898 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 9 0.0005
899 NEOPLASM MALIGNANT 35 0.0005
900 ANGINA PECTORIS 15 0.0005
901 DELIRIUM 18 0.0005
902 GASTROINTESTINAL HAEMORRHAGE 43 0.0005
903 INTENTIONAL OVERDOSE 33 0.0005
904 HYPERKALAEMIA 18 0.0005
905 ACUTE MYOCARDIAL INFARCTION 15 0.0005
906 RESPIRATORY FAILURE 37 0.0005
907 HAEMOGLOBIN DECREASED 52 0.0005
908 DRUG RESISTANCE 13 0.0005
909 AGGRESSION 25 0.0005
910 PREGNANCY 10 0.0005
911 PSORIASIS 65 0.0005
912 APHASIA 15 0.0005
913 BONE DISORDER 9 0.0005
914 PANCREATITIS ACUTE 11 0.0005
915 INJECTION SITE HAEMORRHAGE 38 0.0005
916 CEREBRAL HAEMORRHAGE 17 0.0005
917 PSYCHOTIC DISORDER 14 0.0005
918 DISEASE PROGRESSION 56 0.0005
919 MOBILITY DECREASED 34 0.0005
920 PANCREATITIS 25 0.0005
921 MUSCULOSKELETAL DISORDER 9 0.0005
922 IMPAIRED WORK ABILITY 10 0.0005
923 ADVERSE EVENT 43 0.0005
924 DYSTONIA 9 0.0005
925 DIABETIC KETOACIDOSIS 11 0.0005
926 ACTIVITIES OF DAILY LIVING IMPAIRED 9 0.0005
927 MELAENA 10 0.0005
928 EMOTIONAL DISORDER 14 0.0005
929 HYPOGLYCAEMIA 22 0.0005
930 NERVOUS SYSTEM DISORDER 14 0.0004
931 PANCYTOPENIA 25 0.0004
932 FEAR 12 0.0004
933 SUICIDE ATTEMPT 27 0.0004
934 OSTEONECROSIS OF JAW 11 0.0004
935 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 15 0.0004
936 BLOOD ALKALINE PHOSPHATASE INCREASED 11 0.0004
937 MULTIPLE SCLEROSIS 21 0.0004
938 GLYCOSYLATED HAEMOGLOBIN INCREASED 11 0.0004
939 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 31 0.0004
940 RESPIRATORY DISTRESS 12 0.0004
941 MULTIPLE ORGAN DYSFUNCTION SYNDROME 12 0.0004
942 NEUTROPENIA 57 0.0004
943 DEVICE DISLOCATION 18 0.0004
944 CEREBROVASCULAR ACCIDENT 70 0.0004
945 HAEMORRHAGE 43 0.0004
946 METABOLIC ACIDOSIS 13 0.0004
947 MYELOSUPPRESSION 14 0.0004
948 HAEMATOMA 10 0.0004
949 RENAL FAILURE 51 0.0004
950 MATERNAL EXPOSURE DURING PREGNANCY 34 0.0004
951 RECTAL HAEMORRHAGE 16 0.0004
952 JAUNDICE 10 0.0004
953 DEVICE LEAKAGE 16 0.0004
954 PALLOR 10 0.0004
955 MYOCARDIAL INFARCTION 64 0.0004
956 TYPE 2 DIABETES MELLITUS 12 0.0004
957 HAEMATEMESIS 9 0.0004
958 BREAST CANCER 33 0.0004
959 CARDIAC ARREST 29 0.0004
960 MULTIPLE SCLEROSIS RELAPSE 24 0.0003
961 NEOPLASM PROGRESSION 12 0.0003
962 MUCOSAL INFLAMMATION 9 0.0003
963 THROMBOCYTOPENIA 38 0.0003
964 BLOOD GLUCOSE INCREASED 64 0.0003
965 EMOTIONAL DISTRESS 41 0.0003
966 PRODUCT SUBSTITUTION ISSUE 19 0.0003
967 GENERAL PHYSICAL HEALTH DETERIORATION 38 0.0003
968 ABORTION SPONTANEOUS 13 0.0003
969 MENTAL STATUS CHANGES 9 0.0003
970 DEVICE BREAKAGE 13 0.0003
971 DEATH 272 0.0003
972 DRUG DOSE OMISSION 52 0.0003
973 CARDIO-RESPIRATORY ARREST 13 0.0003
974 RENAL FAILURE ACUTE 13 0.0003
975 IMPAIRED HEALING 10 0.0003
976 DEVICE ISSUE 27 0.0003
977 VISUAL ACUITY REDUCED 10 0.0003
978 FOETAL EXPOSURE DURING PREGNANCY 24 0.0003
979 LUNG NEOPLASM MALIGNANT 12 0.0003
980 CONVULSION 16 0.0003
981 OSTEONECROSIS 9 0.0003
982 VAGINAL HAEMORRHAGE 11 0.0003
983 LEUKOPENIA 12 0.0002
984 DRUG WITHDRAWAL SYNDROME 21 0.0002
985 DRUG DEPENDENCE 37 0.0002
986 TREATMENT FAILURE 17 0.0002
987 DEVICE DIFFICULT TO USE 13 0.0002
988 TOXICITY TO VARIOUS AGENTS 29 0.0002
989 DEVICE MALFUNCTION 12 0.0002
990 COMPLETED SUICIDE 14 0.0002